TABLE 2.

Demographic and Clinical Characteristics of Survivors and Nonsurvivors

Variable*Survivor (N = 1867)Nonsurvivor (N = 75)P
Age, mo10.0 (0.7–48.0)1.0 (0.0–24.0)<.001
Male gender, n (%)1041 (55.8%)41 (54.7%).946
Prematurity, n (%)77 (4.1%)14 (18.7%)<.001
PRISM score4 (0–6)14 (4–26.5)<.001
Admitted to ICU, n (%)1032 (55.3%)70 (93.3%)<.001
CPOE, n (%)512 (27.4%)36 (48.0%)<.001
Airway/respiratory, n (%)788 (42.2%)40 (53.3%).073
Infectious disease, n (%)661 (35.4%)16 (21.3%).017
CNS/neuromuscular, n (%)365 (19.6%)12 (16.0%).540
Surgical referral, n (%)322 (17.2%)24 (32.0%).002
Gastrointestinal, n (%)258 (13.8%)7 (9.3%).348
GCS score ≤8, n/N (%)208/1853 (11.2%)37/74 (50.0%)<.001
Metabolic/renal/ingestion, n (%)220 (11.8%)1 (1.3%).009
Cardiovascular, n (%)141 (7.6%)18 (24.0%)<.001
Shock, n (%)138 (7.4%)18 (24.0%)<.001
Congenital/genetic, n (%)84 (4.5%)9 (12.0%).007
Hematologic/oncologic, n (%)55 (2.9%)2 (2.7%)1.000
Other diagnosis, n (%)50 (2.7%)2 (2.7%)1.000
ECMO referral, n (%)27 (1.4%)7 (9.3%)<.001
  • * Clinical categories are not mutually exclusive (eg, meningococcemia = infectious disease and shock). Continuous data are presented as median (interquartile range). Categorical data are presented as percentages of survivors and nonsurvivors.

  • P values reflect comparisons between survivors and nonsurvivors, as determined by Mann-Whitney rank sum test for continuous data and χ2 or Fisher's exact tests for categorical data.